Detalles de la búsqueda
1.
Adaptive immunity induces mutualism between commensal eukaryotes.
Nature
; 596(7870): 114-118, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262174
2.
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.
Am J Hum Genet
; 108(3): 431-445, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600772
3.
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Clin Gastroenterol Hepatol
; 2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743037
4.
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
Gastroenterology
; 161(3): 837-852.e9, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34052278
5.
Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(9): 1807-1813.e1, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267862
6.
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Gastroenterology
; 155(4): 1098-1108.e9, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29964043
7.
Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Am J Gastroenterol
; 118(11): 2084-2087, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207296
8.
Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Dig Dis Sci
; 62(8): 2126-2132, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28050782
9.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
Gastroenterology
; 149(6): 1575-1586, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26278503
10.
Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease.
J Crohns Colitis
; 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224550
11.
TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response.
medRxiv
; 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38370739
12.
A Rare Cause of Diarrhea and Polyposis.
Gastroenterology
; 153(6): 1490-1491, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28865735
13.
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
Clin Gastroenterol Hepatol
; 11(3): 286-92; quiz e24, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23200982
14.
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Am J Gastroenterol
; 108(12): 1891-900, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24126633
15.
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(1): 43-55, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240801
16.
Randomized, controlled trial of standard, large-capacity versus jumbo biopsy forceps for polypectomy of small, sessile, colorectal polyps.
Gastrointest Endosc
; 75(1): 118-26, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22196811
17.
Biodiversity influences the effects of oil disturbance on coastal ecosystems.
Ecol Evol
; 12(1): e8532, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35127038
18.
MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity.
Pharmaceuticals (Basel)
; 15(12)2022 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36558958
19.
Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
Cancer Lett
; 549: 215915, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113636
20.
NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.
Am J Gastroenterol
; 105(2): 378-86, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19826411